<i>Campylobacter jejuni</i>/<i>coli</i> Infection: Is It Still a Concern?
Campylobacteriosis is a leading cause of infectious diarrhea and foodborne illness worldwide. <i>Campylobacter</i> infection is primarily transmitted through the consumption of contaminated food, especially uncooked meat, or untreated water; contact with infected animals or contaminated...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Microorganisms |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-2607/12/12/2669 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846103478870474752 |
|---|---|
| author | Piero Veronese Icilio Dodi |
| author_facet | Piero Veronese Icilio Dodi |
| author_sort | Piero Veronese |
| collection | DOAJ |
| description | Campylobacteriosis is a leading cause of infectious diarrhea and foodborne illness worldwide. <i>Campylobacter</i> infection is primarily transmitted through the consumption of contaminated food, especially uncooked meat, or untreated water; contact with infected animals or contaminated environments; poultry is the primary reservoir and source of human transmission. The clinical spectrum of <i>Campylobacter jejuni</i>/<i>coli</i> infection can be classified into two distinct categories: gastrointestinal and extraintestinal manifestations. Late complications are reactive arthritis, Guillain–Barré syndrome, and Miller Fisher syndrome. In the pediatric population, the 0–4 age group has the highest incidence of campylobacteriosis. Regarding the use of specific antimicrobial therapy, international guidelines agree in recommending it for severe intestinal infections. Host factors, including malnutrition, immunodeficiency, and malignancy, can also influence the decision to treat. The Centers for Disease Control and Prevention (CDC) has identified antibiotic resistance in <i>Campylobacter</i> as a ‘significant public health threat’ due to increasing resistance to FQs or macrolides. Although numerous vaccines have been proposed in recent years to reduce the intestinal colonization of poultry, none have shown sufficient efficacy to provide a definitive solution. |
| format | Article |
| id | doaj-art-0bd568b67cb7481e83bcc3908fb8dfd0 |
| institution | Kabale University |
| issn | 2076-2607 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Microorganisms |
| spelling | doaj-art-0bd568b67cb7481e83bcc3908fb8dfd02024-12-27T14:41:54ZengMDPI AGMicroorganisms2076-26072024-12-011212266910.3390/microorganisms12122669<i>Campylobacter jejuni</i>/<i>coli</i> Infection: Is It Still a Concern?Piero Veronese0Icilio Dodi1Pediatric Infectious Disease Unit, Barilla Children’s Hospital of Parma, 43126 Parma, ItalyPediatric Infectious Disease Unit, Barilla Children’s Hospital of Parma, 43126 Parma, ItalyCampylobacteriosis is a leading cause of infectious diarrhea and foodborne illness worldwide. <i>Campylobacter</i> infection is primarily transmitted through the consumption of contaminated food, especially uncooked meat, or untreated water; contact with infected animals or contaminated environments; poultry is the primary reservoir and source of human transmission. The clinical spectrum of <i>Campylobacter jejuni</i>/<i>coli</i> infection can be classified into two distinct categories: gastrointestinal and extraintestinal manifestations. Late complications are reactive arthritis, Guillain–Barré syndrome, and Miller Fisher syndrome. In the pediatric population, the 0–4 age group has the highest incidence of campylobacteriosis. Regarding the use of specific antimicrobial therapy, international guidelines agree in recommending it for severe intestinal infections. Host factors, including malnutrition, immunodeficiency, and malignancy, can also influence the decision to treat. The Centers for Disease Control and Prevention (CDC) has identified antibiotic resistance in <i>Campylobacter</i> as a ‘significant public health threat’ due to increasing resistance to FQs or macrolides. Although numerous vaccines have been proposed in recent years to reduce the intestinal colonization of poultry, none have shown sufficient efficacy to provide a definitive solution.https://www.mdpi.com/2076-2607/12/12/2669<i>Campylobacter</i>foodborne illnessantibiotic resistancepediatric population |
| spellingShingle | Piero Veronese Icilio Dodi <i>Campylobacter jejuni</i>/<i>coli</i> Infection: Is It Still a Concern? Microorganisms <i>Campylobacter</i> foodborne illness antibiotic resistance pediatric population |
| title | <i>Campylobacter jejuni</i>/<i>coli</i> Infection: Is It Still a Concern? |
| title_full | <i>Campylobacter jejuni</i>/<i>coli</i> Infection: Is It Still a Concern? |
| title_fullStr | <i>Campylobacter jejuni</i>/<i>coli</i> Infection: Is It Still a Concern? |
| title_full_unstemmed | <i>Campylobacter jejuni</i>/<i>coli</i> Infection: Is It Still a Concern? |
| title_short | <i>Campylobacter jejuni</i>/<i>coli</i> Infection: Is It Still a Concern? |
| title_sort | i campylobacter jejuni i i coli i infection is it still a concern |
| topic | <i>Campylobacter</i> foodborne illness antibiotic resistance pediatric population |
| url | https://www.mdpi.com/2076-2607/12/12/2669 |
| work_keys_str_mv | AT pieroveronese icampylobacterjejuniiicoliiinfectionisitstillaconcern AT iciliododi icampylobacterjejuniiicoliiinfectionisitstillaconcern |